Trial · NCT01543178
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Open-label Period | STARTED | Open-label Rifaximin | 2,583 | |
| Open-label Period | STARTED | Double-blind Rifaximin (Retreatment) | 0 | |
| Open-label Period | STARTED | Double-blind Placebo (Retreatment) | 0 | |
| Open-label Period | COMPLETED | Open-label Rifaximin | 636 | |
| Open-label Period | COMPLETED | Double-blind Rifaximin (Retreatment) | 0 | |
| Open-label Period | COMPLETED | Double-blind Placebo (Retreatment) | 0 | |
| Open-label Period | NOT COMPLETED | Open-label Rifaximin | 1,947 | |
| Open-label Period | NOT COMPLETED | Double-blind Rifaximin (Retreatment) | 0 | |
| Open-label Period | NOT COMPLETED | Double-blind Placebo (Retreatment) | 0 | |
| Double-blind Period | STARTED | Open-label Rifaximin | 0 | |
| Double-blind Period | STARTED | Double-blind Rifaximin (Retreatment) | 328 | |
| Double-blind Period | STARTED | Double-blind Placebo (Retreatment) | 308 | |
| Double-blind Period | COMPLETED | Open-label Rifaximin | 0 | |
| Double-blind Period | COMPLETED | Double-blind Rifaximin (Retreatment) | 284 | |
| Double-blind Period | COMPLETED | Double-blind Placebo (Retreatment) | 271 | |
| Double-blind Period | NOT COMPLETED | Open-label Rifaximin | 0 | |
| Double-blind Period | NOT COMPLETED | Double-blind Rifaximin (Retreatment) | 44 | |
| Double-blind Period | NOT COMPLETED | Double-blind Placebo (Retreatment) | 37 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01543178/flow